Center for Applied Medical Research (CIMA), Department of Gene Therapy and Regulation of Gene Expression, University of Navarra, Pamplona, Spain.
Nat Med. 2015 Nov;21(11):1253-61. doi: 10.1038/nm.3981.
It is increasingly evident that many of the genomic mutations in cancer reside inside regions that do not encode proteins. However, these regions are often transcribed into long noncoding RNAs (lncRNAs). The recent application of next-generation sequencing to a growing number of cancer transcriptomes has indeed revealed thousands of lncRNAs whose aberrant expression is associated with different cancer types. Among the few that have been functionally characterized, several have been linked to malignant transformation. Notably, these lncRNAs have key roles in gene regulation and thus affect various aspects of cellular homeostasis, including proliferation, survival, migration or genomic stability. This review aims to summarize current knowledge of lncRNAs from the cancer perspective. It discusses the strategies that led to the identification of cancer-related lncRNAs and the methodologies and challenges involving the study of these molecules, as well as the imminent applications of these findings to the clinic.
越来越明显的是,癌症中的许多基因组突变存在于不编码蛋白质的区域内。然而,这些区域通常被转录为长非编码 RNA(lncRNA)。最近,下一代测序技术在越来越多的癌症转录组中的应用确实揭示了数千种 lncRNA,它们的异常表达与不同的癌症类型有关。在少数已被功能表征的 lncRNA 中,有几种与恶性转化有关。值得注意的是,这些 lncRNA 在基因调控中具有关键作用,因此会影响细胞内稳态的各个方面,包括增殖、存活、迁移或基因组稳定性。这篇综述旨在从癌症的角度总结 lncRNA 的最新知识。它讨论了导致鉴定与癌症相关的 lncRNA 的策略,以及研究这些分子所涉及的方法和挑战,以及这些发现对临床的迫切应用。